Medical Enzyme Technology Market Scope, Analysis, and Trends by 2028
Medical Enzyme Technology Market Report Scope
Report Attribute | Details |
---|---|
Market size in 2020 | US$ 4.01 Billion |
Market Size by 2028 | US$ 6.7 Billion |
Global CAGR (2020 - 2028) | 6.7% |
Historical Data | 2018-2019 |
Forecast period | 2021-2028 |
Segments Covered |
By Enzyme Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
By Enzyme Type
- Digestive Enzyme
- L-asparaginase
- Lactase
- Others
- Thrombolytic Enzyme
- Streptokinase
- Urokinase
- Others
- Hydrolases Enzyme
- Hyaluronidase
- Lysozymes
- Others
- Endonucleases Enzyme
- Benzonase
- Others
By Application
- Disease Treatments
- Diagnostic Tools
- Biomedical Research
- Others
By
Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Merck
- Thermo Fisher Scientific Inc.
- Novozymes
- TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Agilent Technologies, Inc.
- Danaher (Cytiva)
- Sanofi
- Asahi Kasei Corporation
- Promega Corporation
- Amano Enzyme Inc
- Genzyme Corporation